Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Galena Biopharma focuses on late-stage targeted cancer drug development

Nov. 2, 2011

Sanofi presents new Met inhibitors

Nov. 2, 2011

Circadian Technologies clear to start clinical development of VGX-100

Nov. 2, 2011

Natural plant-derived product inhibits proliferation of gastric cancer cells

Nov. 2, 2011

BerGenBio begins preclinical development of lead product

Oct. 31, 2011

New phase Ib/II study of BEZ-235 launched

Oct. 31, 2011

Acceleron Pharma begins phase II trial of ACE-041 in head and neck cancer

Oct. 31, 2011

Eviendep may alter neoproliferative processes in intestinal mucosa

Oct. 31, 2011

European Commission extends Alimta approval

Oct. 28, 2011

Researchers at Abbott claim novel inhibitors of Bcl-2

Oct. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...